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Introduction
• Chronic, inflammatory, recurrent, debilitating, skin 
follicular disease in the apocrine gland-bearing area of 
the body 
• Chronic and debilitating inflammatory disease
• Estimated to be over 325,000 patients in the US
• Mean onset 22y/o +- 8 years
Background
• Average 5-14 year diagnostic delay from onset of symptoms
• Patients often receive sporadic care only during flare-ups.
• Medical treatment options include topical and oral antibiotics
• Growing evidence for biologic agents for disease suppression
• Surgical treatment is often required however ideal timing is 
unclear
• Multidisciplinary clinic formed to optimize management
• Plastic Surgery, Dermatology, Infectious Disease, Gynecology, Internal 
Medicine
Objective
• Review Multidisciplinary Clinic experience
• Evaluate for factors which affect complete healing at two 
years post-surgery in patients
• Patient demographics and comorbidities
• Disease severity and location
• Surgical treatment modality
• Multidisciplinary follow-up
• Treatment with biologic agents
Patient Characteristics
Patient Demographics N (%)
Total Patients 248
Female gender 186 (75%)
African American 214 (88%)
Body mass index, kg/m2, mean + SD 26 + 10
Age of initial diagnosis, mean + SD 29 + 9
Age at presentation, mean + SD 45 + 17
Family history of hidradenitis suppurativa 139 (56%)
Diabetes 57 (23%)
Tobacco use (45) 18%
Inflammatory bowel disease or Crohn’s diagnosis (35 )14%
Connective tissue disease diagnosis 96 (39%)
Use of antibiotics* 181 (73%)
Use of immunomodulating medications 57 (23%)
• Three-year retrospective review of patient’s 
referred through HSMC 
• All patients underwent surgery
• Incision and drainage with fulguration 
• Excision with or without reconstruction
• Minimum of 24 month follow-up
Distribution of Involvement
Site n % of 
patients
Axilla 124 50%
Groin 152 61.2%
Perineum 117 47%
Buttock 47 19%
Perianal 2 1%
Abdomen 30 12.2%
Breast 31 12.3%
Scrotum 13 5%
Neck 5 2%
Back 2 1%
Pilonidal 15 6%
Scalp 1 0.5%
Axilla
GroinPerineum
PERCENTAGE OF TOTAL SITES
Hurley Stage
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Hurley Stage*
Number of involved 
sites
Percent of 
total sites
Percent of 
sites healed
1 131 17% 80%
2 442 56% 80%
3 210 27% 74%
Surgical Treatment and Healing
Repair Healed (%) Not Healed
Incision 224 (79%) 58 
Excision 250 (78%) 72
Repair 90 (68%) 42
Total 564 (76%) 172
Variable OR (95% CI) p-value
Biologic treatment
Use within 2 weeks of surgery 0.23 (0.08, 0.64) 0.005*
Held > 2 weeks before surgery     1.99 (0.79, 5.01) 0.146
Diabetes 1.02 (0.52, 2.01) 0.094
Body mass index 0.98 (0.94, 1.03) 0.445
Hemoglobin 1.05 (0.84, 1.32) 0.666
Female gender 1.09 (0.73, 2.04) 0.748
Family history of hidradenitis suppurativa 1.39 (0.48, 2.83) 0.812
Tobacco use 0.87 (0.44, 3.62) 0.849
Highest severity 0.281
Hurley Stage 2 .99 (0.19, 5.03) 0.987
Hurley Stage 3 0.61 (0.12, 2.98) 0.539
Number of involved sites 0.721
2 0.92 (0.29, 2.95) 0.884
3 1.48 (0.43, 5.10) 0.537
• HSMC Largest single 
predictor of healing
• 78% vs. 45% (p=0.004)
• Not significant factors for 
healing
• Gender
• Age
• Body mass index
• Tobacco use
• Diabetes
• Pre-surgery hemoglobin
• Family history of HS 
Conclusions
• Multidisciplinary care is paramount for long term healing
• Hurley stage and number of involved sites did not affect 2 year 
healing rates
• Ablative procedures resulted in complete healing more often 
than primary reconstruction
• If using biologic agents, use within two weeks of surgery may 
negatively affect healing 
